ENDPOINTS

Foodsmart names former Amwell executive Kurt Knight as CEO

Mar 18, 2025  0

Nutrition telehealth company Foodsmart tapped Kurt Knight, a former Amwell execu...

Japan's RegCell raises $45.8M for Treg cell therapies, ...

Mar 18, 2025  0

Cell therapy biotech RegCell is hoping to bridge science from Japan with the US ...

Novartis to cut 400+ staffers in revamp of cardiovascul...

Mar 18, 2025  0

Novartis is laying off at least 400 workers at its US headquarters in East Hanov...

CRISPR startup Arbor Biotechnologies raises $73.9M as i...

Mar 18, 2025  0

Arbor Biotechnologies, a startup founded by CRISPR pioneer Feng Zhang nine years...

Sofinnova raises €165M for new early-stage biotech fund

Mar 18, 2025  0

European life sciences investor Sofinnova Partners disclosed a €165 million acce...

FDA staff return to White Oak campus after Trump admini...

Mar 17, 2025  0

Packed parking, long security lines and traffic greeted returning FDA workers on...

Trump’s HHS defends Biden-era stance on 340B rebate models

Mar 17, 2025  0

The Trump administration defended HHS’ rejection of drugmakers' 340B rebate mode...

AstraZeneca inks deal with Alteogen for subcutaneous ca...

Mar 17, 2025  0

AstraZeneca is betting roughly $1.35 billion on Korean biotech Alteogen to help ...

WuXi AppTec's US revenue growth continues to dip in pos...

Mar 17, 2025  0

A year after the Biosecure Act was introduced, WuXi AppTec’s US revenue growth c...

All selected drugmakers agree to round 2 of price negot...

Mar 17, 2025  0

The second round of Medicare price negotiations is now underway for all 15 selec...

AstraZeneca reports Phase 3 win for hypoparathyroidism ...

Mar 17, 2025  0

AstraZeneca’s $1.05 billion bet on French biotech Amolyt Pharma seems to be payi...

All selected drugmakers agreed to round 2 of price nego...

Mar 17, 2025  0

The second round of Medicare price negotiations is now underway for all 15 selec...

Incyte's stock sinks as povorcitinib disappoints in hid...

Mar 17, 2025  0

Orca Bio's T cell therapy may help blood cancer patient...

Mar 17, 2025  0

Orca Bio on Monday said its T cell therapy, when used in people with certain blo...

Vertanical’s Phase 3 win for non-opioid painkiller; Apr...

Mar 17, 2025  0

Plus, news about Pillar, vTv Therapeutics, OPKO Health, Entera Bio, Zentalis, Su...

AstraZeneca spotlights first-in-human data for B7-H4-ta...

Mar 17, 2025  0

AstraZeneca is fine-tuning plans for a Phase 3 study for its B7-H4-targeting ADC...